Amgen Inc. (NASDAQ: AMGN) is a large market cap stock with a market cap of 130786.65. It is in the Biotechnology industry and sector Healthcare, with a current P/E of 18.43, a forward P/E of 14.05 and EPS of 9.45. At a stock price of 173 (-0.66%) it has a dividend yield of 2.30%.
EPS growth for the last five years have been 13.60%, more recently this last year it has grown by 35.20%. The next year growth is going to be about 9.30% and more long-term 8.50% after five years. EPS growth quarter over quarter is 13.10%. Sales growth for the past five years have been 7.60% and sales growth quarter over quarter is 5.90%.
For performance, Amgen Inc. the past week has seen a gain of 3.86%. For the last month performance for Amgen Inc. is 12.88%. While the last quarter is 12.12% and half year, 17.59%. Finally for the year, performance is 1.51%.
The 52-week high for Amgen Inc., is at -1.98%, and for the 52-week low it comes to a value of 35.47%. The 20-day simple moving average is 9.45% and 12.28% for the 200-day simple moving average.
Volatility for the week is at 1.97%, and for the month it is 1.61%. Amgen Inc., has a target price of 189.94.
In terms of debt, long term debt/equity is *TBA, and for total debt/equity Amgen Inc. has *TBA. The gross margin is 81.00%, while operating margin is 41.30%, the profit margin is *TBA. The current ratio is 4 and the quick ratio is 3.7.
Insider ownership is at 0.20%, with instituitional ownership at 81.70%. Amgen Inc. has a payout ratio of *TBA. With the total shares outstanding coming to 751. The shares float is 750.35, with the float short at 1.04%, with short ratio coming to 2.67.
In terms of returns, the return on assets see Amgen Inc., get *TBA, with its returns on investment at 12.50%. Return on equity is *TBA. So will the investors see the target price of 189.94, reached soon?
Disclaimer: Remember there is a risk to your investment, this is not a recommendation, nor personal advice, never invest more than you are able too loose.